Short seller Norris: Covid vaccines are no ‘silver bullet’

Barry Norris, founder and chief executive of Argonaut Capital, tells us why he thinks the market reaction to coronavirus vaccine breakthroughs has been too positive, how short-selling does more good for society than ESG investing, and why he is considering expanding the universe of his European long-only funds to include global stocks.